TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 11/13/23

2023-11-13 02:36:21 ET Japan ( NKY:IND ) +0.05% Japan PPI for October -0.4% m/m (expected 0.0%) and +0.8% y/y (expected +0.9%). China ( SHCOMP ) +0.25% . Hong Kong ( HSI ) +0.61% . India ( SENSEX ) -0.49% . Total passenger...

2023-11-10 02:53:35 ET Japan ( NKY:IND ) -0.24% . China ( SHCOMP ) -0.47%. China's vehicle sales continue thrive, New Energy Vehicles (NEV) sales rocketing by 33.5%. October vehicle sales were up 13.8% y/y (from September's +9.5%). Hong Kong&...

cTTP is an Ultra-rare Blood Clotting Disorder Associated with Life-Threatening Acute Events and Debilitating Chronic Symptoms Takeda Continues 70-plus Year Legacy of Driving Innovation for the Rare Hematology Community Takeda ( TSE:4502/NYSE:TAK ) tod...

2023-11-09 07:21:50 ET More on HUTCHMED, Takeda, etc. Takeda Pharmaceutical Company Limited (TAK) Q2 2023 Earnings Call Transcript Takeda: Why I'm Staying Bearish On This Generic Drug Dividend Play Hutchmed: Progressing, But We Would Like More Clarity On Profit Margi...

2023-11-09 03:10:08 ET Japan ( NKY:IND ) +1.49% . Japan's current account surplus surged to JPY 2,726.3 billion in September 2023 from JPY 853.08 billion in the same month a year earlier but less than market estimates of a gain of JPY 3,000.8 billion. The gauge for Japa...

− FRUZAQLA is the First Targeted Therapy Approved for Metastatic Colorectal Cancer (mCRC) Regardless of Biomarker Status or Prior Types of Therapies in More Than a Decade − FRUZAQLA Plus Best Supportive Care Demonstrated Significant Improvements in Overall Survival, ...

2023-11-08 03:12:05 ET Japan ( NKY:IND ) -0.33% . The Reuters Tankan sentiment index for manufacturers in Japan rose to +6 in November 2023 from +4 in October, showing an improvement in business confidence for the first time since August. Reserve assets in Japan rose sl...

2023-11-07 16:00:06 ET There are very good reasons that stocks generally gain in value after a company receives %OrphanDrug designation (ODD). A study published in Orphanet Journal of Rare Diseases showed that the average stock price of a company increased by 3.36% after the announc...

− The Study Met Its Primary Endpoint with 53.3% and 54.2% of Patients Treated With TAK-279 (15 mg and 30 mg Respectively) Achieving At Least an ACR 20 Response Compared to 29.2% in the Placebo Group at Week 12 (p = 0.002) 1 − TAK-279 Demonstrated Improvem...

2023-11-07 03:10:18 ET Japan ( NKY:IND ) -1.34% . Japan data - September Household Spending -2.8% y/y (vs. expected -2.7%). Japan data - September Labor Cash Earnings +1.2% y/y (expected +1.0%). China ( SHCOMP ) -0.04%. China October exports -6.4% ...